Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event
Completed
- Conditions
- Cardiovascular Events
- Registration Number
- NCT01395550
- Lead Sponsor
- AstraZeneca
- Brief Summary
AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
- All patients who has experienced cardiovascular events
Exclusion Criteria
- Patients with no cardiovascular events.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method